Connect with us


Obaseki Under Attack for Mandatory Vaccination in Edo State



do State Governor, Godwin Obaseki is been attacked by Edo people and Nigerians for mandating presentation of Covid-19 Vaccination certificates in the state.

“The presentation of certificates of COVID-19 vaccination will from the second week of September be compulsory  for entry into areas of large gatherings like churches, mosques, banks, wedding, and burial places”.

Edo Governor, Godwin Obaseki said this kicking off the second phase of the COVID-19 vaccination at the Government House, Benin on Monday.

Obaseki  explained that the proposed measure was informed by the   devastating effects of  the third wave of the virus in the country.

He pointed out that the latest reports indicate that 96 percent of persons infected with Delta variant had  not been vaccinated.

The governor  said: “From what we have seen so far, the COVID-19 is here to stay. There may be other waves. We need to find a solution. That is why vaccination is very important.

Read Other Related Articles:



This policy by the Governor however doesn’t sit well with people of the state and many other concerned Nigerians. In a publication he made on his official Facebook page, the Governor released venues where Vaccination takes place in the state.

Reactions that trailed the publication showed the people are against forceful vaccination in the South South state.

“so call health facilities? Mr governor, leave this vaccination matter. It will not work. You can not continue with the race anymore. It is already a failed plan”. – One of the comment said


Maurice Yeptei wrote;

You are now the WHO president abi? Twale. Use the analysis to build schools, create roads, empower youths. Charge your lap technicians, your doctors and nurses on research and development of the vaccine, instead of wasting Edo’s money on foreign medicines that are even a donation. What is really wrong with our leaders in this country?

Onaghinor Osa James said – “It’s a good development. But Sir vaccination is a right not a force. Prevention and awareness is what they need. Even here in advance countries where it was worst. People were not forced. People have their rights. Sir”

Engr Jimmy Coker EyeSpy repliedThis is unconstitutional, it’s against human right and its oppression to force anyone to take the vaccine against their will, what Edo need is good roads, electricity, schools, security, etc. for over a year now Edo is without state assembly, local government chairmen or counselors, mass vaccination is the last thing we the Edo people are craving at the moment…this is not a good plan.


Simon Blizz also wrote;

Mr Governor Sir, Covid-19 Vaccine is not really the problem of our citizens, people are dying of hunger on daily basis, no job, no good road’s, if it rains a lot of person’s can’t access their home due to bad road’s all over the state, please swing in to action, close to a year now you couldn’t appoint cabinet members to assist you to run your administration, 5 of you’re ruling the state right now as it’s, please his Excellency save your reputation by doing the needful


Reactions As Saudi Arabia Recruits Nigerian Medical Experts In Abuja



igerian Medical Association, Medical and Dental Consultants Association of Nigeria (MDCAN), Association of Medical Doctors in the Academics and the striking National Association of Resident Doctors (NARD), among others have been called by some concerned Nigerians, following the news and video about recruitment of its personnel by the Saudi Arabian authority.

In a video seen by Okanga Trumpeters, overwhelming number of Nigerian medical experts were seen during the physical recruitment exercise held in Sharaton Hotel Abuja, Nigeria  by Saudi authority.

In a video posted by Objectv Media, some medical doctors vented their annoyance and disappointment with the Nigerian Government, admitting lack of concern and care for their welfare. They said they have to apply for jobs overseas because their basic needs here are not provided.

Read Other Related Articles:



Resident Doctors in Nigeria have been on strike for more than a month and sadly series of negotiations with the Federal Government have yielded no result. speaking during the recruitment by Saudi authority, one of the striking doctors said “It is sad that the government is not even doing anything about it. And you can imagine my Honorable Minister of health came out and he threatened us” – the speaker alleged

“It doesn’t make sense and it worsen the whole situation. To be candid, we are very very disappointed, I personally, am very disappointed” .

Speaking further, he said he work in a very critical department in a hospital and many a time, he would use his personal money to purchase some of the things the hospital may need, just for sake of the patients.

Another doctor, who remained anonymous said he was applying for the Saudi job to escape the ills of the Nigerian society. “A lot of discouraging things, you see banditry, you see kidnapping, incessant strike and among others. If someone can get a place where he can work,  place that is calm and place where one can use his skills, is it not better to go there?”.

Vivian Okolo, who is a female medical doctor said “I left medical school April, 2011, and I’m surprised to see my teacher here too. You know what it means? my teacher that taught me how many years ago. I’m giving up on the country, on our leaders. This is the worst i have seen, i never knew it has gone this bad – She said

See Video Below:

Continue Reading


Bad Medication Habits You Should Avoid – Pharm Yusuf



ealth expert, Pharm Adebisi Yusuf shares bad mediation habits, especially that which is usually seen among Nigerians.
The concise but worthy habits he advised should be stopped include:
1. Dividing the contents of capsules.
E.g., dividing Ampiclox capsule for children. You will end up giving inaccurate doses (you can’t gauge doses with eyes). Also, drugs are made into capsules to ensure they are released/absorbed exactly where needed. Opening up such could make the drug ineffective as well as expose you to unwanted side effects. Capsules should be swallowed whole (except directed otherwise by an expert).
2. Not completing your dose because you feel better can lead to incomplete treatment, relapse of the disease, and drug resistance. Please always complete your dose.
3. Using antibiotics for everything.
Antibiotics only treat diseases caused by bacteria, they are not the solution to EVERYTHING. Use only when clearly needed.
4. Using multiple pain killers of the same class.
E.g., using Ibuprofen+Diclofenac+Piroxicam. This can cause injury to your stomach (ulcer) and put you at risk of severe side effects.
5. Sharing your medications with relatives/friends, because it works for you does not mean it is appropriate for another person. Your friend may have a condition that makes the drug inappropriate for him/her.
Continue Reading


Covid-19 Could Be Treated For Under $1 Daily – Israeli Scientist Says



vermectin, a drug used to fight parasites in third-world countries, could help reduce the length of infection for people who contract coronavirus for less than a $1 a day, according to recent research by Sheba Medical Center in Tel Hashomer.
Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba, conducted a randomized, controlled, double-blinded trial from May 15, 2020, through the end of January 2021 to evaluate the effectiveness of ivermectin in reducing viral shedding among nonhospitalized patients with mild to moderate COVID-19.
Ivermectin has been approved by the US Food and Drug Administration since 1987. The drug’s discoverers were awarded the 2015 Nobel Prize in medicine for its treatment of onchocerciasis, a disease caused by infection with a parasitic roundworm.



Over the years, it has been used for other indications, including scabies and head lice. Moreover, in the last decade, several clinical studies have started to show its antiviral activity against viruses ranging from HIV and the flu to Zika and West Nile.
The drug is also extremely economical. A study published in the peer-reviewed American Journal of Therapeutics showed that the cost of ivermectin for other treatments in Bangladesh is around $0.60 to $1.80 for a five-day course. It costs up to $10 a day in Israel, Schwartz said.
In Schwartz’s study, some 89 eligible volunteers over the age of 18 who were diagnosed with coronavirus  and staying in state-run COVID-19 hotels were divided into two groups: 50% received ivermectin, and 50% received a placebo, according to their weight. They were given the pills for three days in a row, an hour before a meal.
The volunteers were tested using a standard nasopharyngeal swab PCR test with the goal of evaluating whether there was a reduction in viral load by the sixth day – the third day after termination of the treatment. They were swabbed every two days.
Nearly 72% of volunteers treated with ivermectin tested negative for the virus by day six. In contrast, only 50% of those who received the placebo tested negative.
IN ADDITION, the study looked at culture viability, meaning how infectious the patients were, and found that only 13% of ivermectin patients were infectious after six days, compared with 50% of the placebo group – almost four times as many.
“Our study shows first and foremost that ivermectin has antiviral activity,” Schwartz said. “It also shows that there is almost a 100% chance that a person will be noninfectious in four to six days, which could lead to shortening isolation time for these people. This could have a huge economic and social impact.”
The study appeared on the MedRxiv health-research sharing site. It has not yet been peer reviewed.
Schwartz said other similar studies – though not all of them conducted to the same double-blind and placebo standards as his – also showed a favorable impact of ivermectin treatment.
His study did not prove ivermectin was effective as a prophylactic, meaning that it could prevent disease, he cautioned, nor did it show that it reduces the chances of hospitalization. However, other studies have shown such evidence, he added.
For example, the study published earlier this year in the American Journal of Therapeutics highlighted that “a review by the Front Line COVID-19 Critical Care Alliance summarized findings from 27 studies on the effects of ivermectin for the prevention and treatment of COVID-19 infection, concluding that ivermectin ‘demonstrates a strong signal of therapeutic efficacy’ against COVID-19.”
“Another recent review found that ivermectin reduced deaths by 75%,” the report said.
BUT IVERMECTIN is not without controversy, and hence, despite the high levels of coronavirus worldwide, neither the FDA nor the World Health Organization have been willing to approve it for use in the fight against the virus.
Prof. Ya’acov Nahmias, a Hebrew University of Jerusalem researcher, has questioned the safety of the drug.
“Ivermectin is a chemical therapeutic agent, and it has significant risks associated with it,” he said in a previous interview. “We should be very cautious about using this type of medication to treat a viral disease that the vast majority of the public is going to recover from even without this treatment.”
During Schwartz’s study, there was not any signal of significant side effects among ivermectin users.
Only five patients were referred to hospitals, with four of them being in the placebo arm. One ivermectin patient went to the hospital complaining of shortness of breath on the day of recruitment. He continued with the ivermectin treatment and was sent back to the hotel a day later in good condition.
The FDA said on its website it “received multiple reports of patients who have required medical support and been hospitalized after self-medicating with ivermectin.”
The “FDA has not approved ivermectin for use in treating or preventing COVID-19 in humans,” it said. “Ivermectin tablets are approved at very specific doses for some parasitic worms, and there are topical (on the skin) formulations for head lice and skin conditions like rosacea. Ivermectin is not an antiviral (a drug for treating viruses). Taking large doses of this drug is dangerous and can cause serious harm.”
The World Health Organization has also recommended against using the drug except in clinical trials.
IN CONTRAST, Schwartz said he was very disappointed that the WHO did not support any trial to determine whether the drug could be viable.
Last month, Oxford University announced a large trial on ivermectin effectiveness.
Schwartz said he became interested in exploring ivermectin about a year ago, “when everyone was looking for a new drug” to treat COVID-19, and a lot of effort was being put into evaluating hydroxychloroquine, so he decided to join the effort.
“Since ivermectin was on my shelf, since we are using it for tropical diseases, and there were hints it might work, I decided to go for it,” he said.
Researchers in other places worldwide began looking into the drug at around the same time. But when they started to see positive results, no one wanted to publish them, Schwartz said.
“There is a lot of opposition,” he said. “We tried to publish it, and it was kicked away by three journals. No one even wanted to hear about it. You have to ask how come when the world is suffering.”
“This drug will not bring any big economic profits,” and so Big Pharma doesn’t want to deal with it, he said.
SOME OF the loudest opposition to ivermectin has come from Merck Co., which manufactured the drug in the 1980s. In a public statement about ivermectin on its website in February, it said: “Company scientists continue to carefully examine the findings of all available and emerging studies of ivermectin for the treatment of COVID-19 for evidence of efficacy and safety. It is important to note that, to date, our analysis has identified no scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies; no meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and a concerning lack of safety data in the majority of studies.”
But Merck has not launched any studies of its own on ivermectin.
“You would think Merck would be happy to hear that ivermectin might be helpful to corona patients and try to study it, but they are most loudly declaring the drug should not be used,” Schwartz said. “A billion people took it. They gave it to them. It’s a real shame.”
And not moving forward with ivermectin could potentially extend the time it takes for the world to be able to live alongside the virus, he said.
“Developing new medications can take years; therefore, identifying existing drugs that can be re-purposed against COVID-19 [and] that already have an established safety profile through decades of use could play a critical role in suppressing or even ending the SARS-CoV-2 pandemic,” wrote the researchers in the American Journal of Therapeutics. “Using re-purposed medications may be especially important because it could take months, possibly years, for much of the world’s population to get vaccinated, particularly among low- to middle-income populations.”
Continue Reading